City of Hope Study Suggests Changing the Gut Microbiome Improves Health Outcomes for People Newly Diagnosed With Metastatic Kidney Cancer
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
New Biomarkers Found to Predict Kidney Failure in Type 1 Diabetes Patients
City of Hope to Present New Research at the AACR Annual Meeting
Mustang Bio and City of Hope’s chimeric antigen receptor T-cell (CAR-T) therapy for recurrent glioblastoma resulted in stable disease or better in half of the subjects in a phase 1 clinical trial, including one patient whose cancer has not recurred for more than five years.
City of Hope Launches First-of-its-Kind Mobile Cancer Prevention and Screening Program
City of Hope, TGen Researchers Develop Machine-Learning Tool to Detect Cancer Earlier via Liquid Biopsy
City of Hope appoints Kristin Higgins, M.D., as chief clinical officer at City of Hope Cancer Center Atlanta
City of Hope Research Reveals an Immune Cell That Can Attack Cancer
City of Hope Cancer Center, Children’s Oncology Group conduct largest trial